- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03086187
The Effects of the Novel Unloading Device "HEPHAISTOS" on Bone, Muscles and Vessels (HEP)
March 15, 2017 updated by: DLR German Aerospace Center
The Effects of a 56day Unilateral Muscular Unloading Intervention With a Novel Device That Allows Normal Ambulation While Reducing Muscle Activation Drastically, on Muscles, Bones and Vessels
11 healthy men used the HEPHAISTOS unloading orthosis in an ambulatory 8 week intervention study.
It greatly reduces calf muscle forces without reducing ground reaction forces.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The 56day unloading intervention with HEPHAISTOS had the following key objectives:
- Primary objective: Assessment and evaluation of bone adaptation.
- Secondary objective: Assessment and evaluation of functional and structural muscular adaptations.
- Third objective: Assessment and evaluation of functional and structural vascular adaptations.
- Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.
Study Type
Interventional
Enrollment (Actual)
11
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Rine Westphalia
-
Cologne, North Rine Westphalia, Germany, 51147
- German Aerospace Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- male
- age: 20-45
- BMI: 20-30
Exclusion Criteria:
- smoking
- professional sports men
- diabetes
- rheumatism
- muscle and joint disease
- bone fractures within 12 months prior to the study
- cruciate ligament rupture within 10 years prior to the study
- metal implants
- participation in any other clinical study within 2 months prior to the study haemophilia
- any blood vessel disease
- epilepsy
- claustrophobia
- herniated disk
- cardiac pulse generator
- drug or alcohol abuse
- hyperlipidaemia
- kidney disease
- hyperhomocysteaemia
- hyper/hypouricemia
- hyper/hypocalcaemia
- anaemia
- vitamin d deficit
- chronical back pain
- deficient certificate of good conduct
- achilles tendon injury
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Hephaistos unloading orthosis
Hephaistos unloading orthosis: Calf muscle unloading: The 11 male subjects had to wear a novel orthosis for 8 weeks, which greatly reduces plantarflexor forces during gait.
|
The Hephaistos unloading orthosis greatly reduces plantarflexor muscle torque and plantarflexor muscle activation during any gait activity.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Bone density as measured with pQCT
Time Frame: At baseline and up to 12 months after the immobilization phase
|
Change from baseline to 14 days after immobilization phase
|
At baseline and up to 12 months after the immobilization phase
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
|
Change in intima & media thickness.
|
At baseline and up to 12 months after the immobilization phase
|
|
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
|
Change in arterial diameter
|
At baseline and up to 12 months after the immobilization phase
|
|
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
|
Change in blood flow
|
At baseline and up to 12 months after the immobilization phase
|
|
Structural and functional parameters of arterial adaptation
Time Frame: At baseline and up to 12 months after the immobilization phase
|
Change in flow-mediated dilation
|
At baseline and up to 12 months after the immobilization phase
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Jörn Rittweger, Prof. Dr., German Aerospace Center (DLR)
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Actual)
August 1, 2011
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
July 31, 2012
First Submitted That Met QC Criteria
March 15, 2017
First Posted (Actual)
March 22, 2017
Study Record Updates
Last Update Posted (Actual)
March 22, 2017
Last Update Submitted That Met QC Criteria
March 15, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HEP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Muscle; Atrophy, General
-
Robert WestermannWithdrawnMuscle Atrophy | ACL Tear | Quadriceps Muscle Atrophy | Muscle Atrophy, ProximalUnited States
-
Athanasios EllinoudisCompletedMuscle Atrophy or Weakness | Muscle Contraction | Core StabilityGreece
-
Ankara Yildirim Beyazıt UniversityCompletedTrapezius Muscle AtrophyTurkey
-
University of JazanCompletedQuadriceps Muscle AtrophySaudi Arabia
-
Cincinnati Sportsmedicine Research and Education...CompletedMuscle Weakness | Severe Muscle AtrophyUnited States
-
University of ValenciaWithdrawnMuscle Atrophy | Muscle Injury
-
University of NottinghamUnknownSarcopenia | Muscle Atrophy | Muscle HypotrophyUnited Kingdom
-
Amsterdam UMC, location VUmcCompletedCritical Illness | Muscle Atrophy or Weakness | Mechanical Ventilation | Diaphragm | Expiratory MuscleNetherlands
-
University Hospital, Basel, SwitzerlandMedical University Innsbruck; University Hospital, Zürich; Cantonal Hospital... and other collaboratorsActive, not recruitingMuscle Weakness | Muscle Atrophy | Muscle Spasticity | Muscle Cramp | Muscle Soreness | Muscle Damage | Myopathy | Muscle InjurySwitzerland, Austria
-
Istanbul UniversityRecruitingEMG | Quadriceps Muscle Atrophy | TourniquetTurkey
Clinical Trials on Hephaistos unloading orthosis
-
DLR German Aerospace CenterCompletedGlucose Metabolism Disorders | Local Glucose Uptake
-
DLR German Aerospace CenterCompletedBone ResorptionGermany
-
Maastricht University Medical CenterCompleted
-
Andrews Research & Education FoundationBREG, IncCompletedOsteoarthritis of the KneeUnited States
-
University of PrimorskaRecruiting
-
York Teaching Hospitals NHS Foundation TrustUniversity of York; University of Salford; York St John UniversityCompletedPeripheral Arterial Disease | Intermittent ClaudicationUnited Kingdom
-
University of UtahUniversity of MinnesotaRecruiting
-
Guy's and St Thomas' NHS Foundation TrustLondon School of Hygiene and Tropical Medicine; King's College London; King's... and other collaboratorsActive, not recruitingCoronary Artery Disease | Ischemic Heart DiseaseUnited Kingdom
-
Abiomed Inc.Completed
-
Amsterdam UMC, location VUmcRecruitingTraumatic Fracture | Spine Fracture | Orthosis | Posterior FixationNetherlands